Login / Signup

Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.

Nicole M EhrhardtVanita R ArodaRodolfo J GalindoAnne L PetersJay H Shubrook
Published in: Clinical diabetes : a publication of the American Diabetes Association (2023)
Keyphrases
  • type diabetes
  • glycemic control
  • metabolic syndrome
  • public health
  • adipose tissue
  • mesenchymal stem cells
  • skeletal muscle
  • cell therapy
  • weight loss